Notice for axatilimab (Specialised Therapeutics Alim Pty Ltd)
Active ingredients
axatilimab
Date of review outcome
Lapse date
Type
Priority review
Indication
For the treatment of chronic graft versus host disease
Therapeutic area
Immunology